International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer

Autor: Leeuwen, M. van, Kieffer, J.M., Efficace, F., Fossa, S.D., Bolla, M., Collette, L., Colombel, M., Giorgi, U. de, Holzner, B., Poll-Franse, L.V.V. de, Poppel, H. van, White, J., Wit, R. de, Osanto, S., Aaronson, N.K., European Org Res Treatment Cancer, Genito-Urinary Cancers Grp, Radiation Oncology Grp, NCRN Testis Clinical Studies Grp

Publikováno v: Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, 15:97. BioMed Central Ltd.
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-14 (2017)
Health and Quality of Life Outcomes, 15(1):97. BioMed Central Ltd.
Health and Quality of Life Outcomes, 15

Background: Understanding of the physical, functional and psychosocial health problems and needs of cancer survivors requires cross-national and cross-cultural standardization of health-related quality of life (HRQoL) questionnaires that capture the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd956d359b7a97801926c702219646b1
https://research.tilburguniversity.edu/en/publications/83acf2da-0fe3-4673-9149-0a4a495892c1

Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: Challenges and opportunities

Autor: Leeuwen, M. van, Efficace, F., Fossa, S.D., Bolla, M., Giorgi, U. de, Wit, R. de, Holzner, B., Poll-Franse, L.V. van de, Poppel, H. van, White, J., Collette, L., Osanto, S., Aaronson, N.K., European Org Res Treatment Canc Q, Genito-Urinary Canc Grp, Radiation Oncology Grp

Publikováno v: European Journal of Cancer, 50(11), 1957-1963
European Journal of Cancer, 50(11), 1957-1963. Elsevier
European Journal of Cancer, 50(11), 1957-1963. Elsevier Ltd.

ObjectivesIn this pilot study we evaluated the feasibility of and methods for assessing the quality of life of long term survivors of European Organisation for Research and Treatment of Cancer (EORTC) phase III clinical trials. Here we report the res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9cbd681c5eaef6ffc9fb378a664fd9
https://doi.org/10.1016/j.ejca.2014.04.018

433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)

Autor: Oudard, S., Benhamouda, N., Escudier, B., Ravel, P., Kothari, D., Mehmud, F., Levionnois, E., Sevin, E., Negrier, S., Barthelemy, P., Berdah, J.F., Ravaud, A., Sternberg, C.N., Bono, P., Porta, C., Giorgi, U. De, Parikh, O., Hawkins, R., Highley, M., Tartour, E., Decker, T., Wilkie, J.

Publikováno v: In European Journal of Cancer September 2015 51 Supplement 3:S89-S90

A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity

Autor: Bacci, G., Ferrari, S., Tienghi, A., Bertoni, F., Mercuri, M., Longhi, A., Fiorentini, G., Forni, C., Bacchini, P., Rimondini, S., Giorgi, U. De, Picci, P.

Publikováno v: European Journal of Surgical Oncology; February 2001, Vol. 27 Issue: 1 p98-104, 7p

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

Autor: Bamias, A¹ abamias@med.uoa.gr, Tzannis, K¹, Harshman, L C², Crabb, S J³, Wong, Y -N⁴, Pal, S Kumar⁵, Giorgi, U De⁶, Ladoire, S⁷, Agarwal, N⁸, Yu, E Y⁹

Publikováno v: Annals of Oncology. Feb2018, Vol. 29 Issue 2, p361-369. 9p. 1 Diagram, 3 Charts, 1 Graph.